Breaking News Instant updates and real-time market news.

NKE

Nike

$53.70

0.47 (0.88%)

17:23
09/26/17
09/26
17:23
09/26/17
17:23

Nike 'bullish' on long-term opportunity in North America.

Says sportswear category a "great way" to bring up city-focused approach.

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

NKE Nike
$53.70

0.47 (0.88%)

09/19/17
BOFA
09/19/17
NO CHANGE
Target $42
BOFA
Underperform
Nike risk/reward remains unfavorable, says BofA/Merrill
BofA/Merrill analyst Robert Ohmes believes Nike to report Q1 earnings next Tuesday above consensus of 48c given conservative guidance but expects a muted outlook due to weakening data points. Ohmes said retail partner same-store sales have deteriorated from last quarter, SportScan data continues to deteriorate, the promotional environment remains elevated, the company continues to lose share to adidas, the e-commerce channel has become a "dumping ground" for clearance and discounting, and VaporMax sales are not yet meaningful. The analyst maintains his Underperform rating and $42 price target on Nike and said risk/reward remains unfavorable.
09/19/17
09/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Market Perform at Wells Fargo with Wells Fargo with analyst Tom Nikic saying with consumers having filled their closets with athletic wear over the past seven years, the category "appears poised to take a breather for now." The analyst cut his price target for the shares to $13 from $17. 2. Kellogg (K) downgraded to Neutral from Overweight at Piper Jaffray with analyst Michael Lavery saying cereal could be at risk from shrinking center store space. 3. Nike (NKE) downgraded to Neutral from Positive at Susquehanna saying that his checks indicate that the North American and European businesses are decelerating as some key categories, especially basketball, have underperformed, resulting in excess inventory that will pressure sales and margins. 4. Synchronoss (SNCR) downgraded to Underperform from Outperform at Raymond James with analyst Tavis McCourt citing the news that Siris Capital is no longer interested in an all-cash transaction for all the outstanding shares of the company and has withdrawn its $18 per share bid from June 22. Further, the analyst believes it increasingly unlikely that the current strategic review will result in an acquisition at a premium and expects share to come under pressure and stay in the range prior to the Siris indication of interest. 5. Sony (SNE) downgraded to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/22/17
PIPR
09/22/17
NO CHANGE
Target $53
PIPR
Neutral
Nike bulls in denial about resurgence of adidas, Piper Jaffray says
Piper Jaffray analyst Erinn Murphy says her intra-quarter reads point to ongoing deceleration in Nike (NKE) momentum, increasing concern around the Jordan brand, which represents 10% of sales, and intensifying promotional pressure on the category domestically. Bulls on Nike are still denying the durability of adidas' (ADDYY) resurgence, Murphy tells investors in a pre-earnings research note. The analyst believes adidas' market share gains have "longer growth sustainability." For Nike's Q1 results on September 26, Murphy sees revenue as inline "at best" and gross margin worse than expected. The analyst, however, sees cost controls driving an earnings beat. Murphy also sees risk to Nike's outlook for Q2. She keeps a Neutral rating on the shares with a $53 price target.
09/26/17
BERN
09/26/17
NO CHANGE
BERN
Survey respondents more likely to buy Nike for fashion/function, says Bernstein
Bernstein analyst Jamie Merriman says he and his firm surveyed 1000 people in the U.S. in July, asking them about 22 athletic apparel and footwear brands. At the athletic apparel and footwear category level, 58% of survey respondents expect to spend about the same amount on the category as they have spent over the last 12 months, while 28% expect to spend more and 14% expect to spend less, he notes. Among those who had shopped the brands in the LTM, the analyst says theintention to purchase more in the NTM was similar across Nike (NKE), adidas (ADDYY) and Under Armour (UAA), while Lululemon (LULU) customers reported the highest intention to purchase more going forward. Additionally, Merriman said respondents were most likely to purchase Nike, relative to other brands, for a combination of fashion and function.

TODAY'S FREE FLY STORIES

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:57
10/17/17
10/17
08:57
10/17/17
08:57
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

08:56
10/17/17
10/17
08:56
10/17/17
08:56
General news
Redbook Store Sales data reported »

Week of 10/14 Redbook…

SRPT

Sarepta

$50.73

0.16 (0.32%)

08:56
10/17/17
10/17
08:56
10/17/17
08:56
Recommendations
Sarepta analyst commentary  »

Sarepta approaching…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

NFLX

Netflix

$202.68

3.19 (1.60%)

, GE

General Electric

$23.36

0.38 (1.65%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Options
Notable open interest changes for October 17th »

Monday's total…

NFLX

Netflix

$202.68

3.19 (1.60%)

GE

General Electric

$23.36

0.38 (1.65%)

CMCSA

Comcast

$36.61

0.6 (1.67%)

BAC

Bank of America

$26.24

0.41 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

08:55
10/17/17
10/17
08:55
10/17/17
08:55
General news
The U.S. trade price report beat estimates »

The U.S. trade price…

NOW

ServiceNow

$121.40

-0.89 (-0.73%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Conference/Events
ServiceNow to hold a forum »

NowForum 2017 is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

  • 26

    Oct

  • 11

    Dec

GSM

Ferroglobe

$14.56

0.39 (2.75%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Conference/Events
Ferroglobe to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

  • 15

    Nov

MSBI

Midland States

$33.03

-0.07 (-0.21%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Conference/Events
Midland States to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 27

    Oct

  • 15

    Nov

HPE

HP Enterprise

$14.86

-0.03 (-0.20%)

08:53
10/17/17
10/17
08:53
10/17/17
08:53
Initiation
HP Enterprise initiated  »

HP Enterprise initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:51
10/17/17
10/17
08:51
10/17/17
08:51
Hot Stocks
Johnson & Johnson says Puerto Rico hurricane had limited impact on company »

Says impact was limited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

PX

Praxair

$141.29

-0.92 (-0.65%)

08:51
10/17/17
10/17
08:51
10/17/17
08:51
Hot Stocks
Praxair signs long-term agreement to supply nitrogen to GLOBALFOUNDRIES »

Praxair has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

ERII

Energy Recovery

$8.21

0.02 (0.24%)

08:49
10/17/17
10/17
08:49
10/17/17
08:49
Initiation
Energy Recovery initiated  »

Energy Recovery initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 16

    May

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:49
10/17/17
10/17
08:49
10/17/17
08:49
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

CSX

CSX

$52.84

0.01 (0.02%)

08:49
10/17/17
10/17
08:49
10/17/17
08:49
Hot Stocks
CSX expects Q4 volume to be neutral »

CSX has a favorable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 29

    Oct

  • 30

    Oct

BOLD

Audentes Therapeutics

$25.00

-3.075 (-10.95%)

08:47
10/17/17
10/17
08:47
10/17/17
08:47
Initiation
Audentes Therapeutics initiated  »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

MS

Morgan Stanley

$48.94

0.64 (1.33%)

08:46
10/17/17
10/17
08:46
10/17/17
08:46
Hot Stocks
Morgan Stanley: MiFID to be 'a little bumpy,' not everyone ready for switchover »

Says believes MiFID will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:46
10/17/17
10/17
08:46
10/17/17
08:46
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

DNKN

Dunkin' Brands

$55.34

-0.13 (-0.23%)

08:46
10/17/17
10/17
08:46
10/17/17
08:46
Recommendations
Dunkin' Brands analyst commentary  »

Dunkin' Brands may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 01

    Nov

  • 02

    Nov

COH

Coach

$39.32

-0.25 (-0.63%)

, TPR

Tapestry

08:45
10/17/17
10/17
08:45
10/17/17
08:45
Recommendations
Coach, Tapestry analyst commentary  »

Coach's new…

COH

Coach

$39.32

-0.25 (-0.63%)

TPR

Tapestry

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$5.99

-0.78 (-11.52%)

, APRN

Blue Apron

$5.25

0.09 (1.74%)

08:45
10/17/17
10/17
08:45
10/17/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

SHLD

Sears

$5.99

-0.78 (-11.52%)

APRN

Blue Apron

$5.25

0.09 (1.74%)

JCP

J.C. Penney

$3.39

-0.02 (-0.59%)

SEAS

SeaWorld

$12.53

-0.59 (-4.50%)

CTL

CenturyLink

$19.76

-0.49 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 07

    Nov

08:45
10/17/17
10/17
08:45
10/17/17
08:45
General news
Treasury Action: yields rebounded from lows »

Treasury Action: yields…

08:44
10/17/17
10/17
08:44
10/17/17
08:44
Conference/Events
Federal Reserve Bank of Philadelphia President speaks at summit »

Federal Reserve Bank of…

ORMP

Oramed

$10.68

-0.1099 (-1.02%)

08:44
10/17/17
10/17
08:44
10/17/17
08:44
Hot Stocks
Oramed scientists-authored paper published in EDM Journal »

Oramed announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:44
10/17/17
10/17
08:44
10/17/17
08:44
Hot Stocks
Trump says Marino withdrew name from drug czar consideration »

President Donald Trump…

NFLX

Netflix

$202.68

3.19 (1.60%)

08:44
10/17/17
10/17
08:44
10/17/17
08:44
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.